- Investing Ideas
- Global Pharmaceuticals & Biotech Healthy potentially undervalued
Global Pharmaceuticals & Biotech Healthy potentially undervalued
Results
191
Companies which are potentially undervalued and in an acceptable financial position.
191 companies
High Tide
Market Cap: CA$274.2m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.10
7D
-3.1%
1Y
-5.5%
Pharma Mar
Market Cap: €1.3b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€77.30
7D
-5.7%
1Y
-4.5%
Trulieve Cannabis
Market Cap: US$1.7b
Operates as a cannabis retailer in the United States.
TRLV
US$9.04
7D
2.5%
1Y
99.6%
Arcutis Biotherapeutics
Market Cap: US$3.5b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$27.12
7D
4.0%
1Y
70.6%
CorMedix
Market Cap: US$659.0m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.32
7D
-5.3%
1Y
-26.8%
Regeneron Pharmaceuticals
Market Cap: US$67.6b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN
US$663.09
7D
2.0%
1Y
16.2%
Hypera
Market Cap: R$14.6b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$20.77
7D
0.4%
1Y
-23.6%
Innovent Biologics
Market Cap: HK$156.8b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$90.05
7D
3.3%
1Y
4.8%
3SBio
Market Cap: HK$43.5b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$17.39
7D
-4.8%
1Y
-39.2%
Zhejiang Jiuzhou Pharmaceutical
Market Cap: CN¥13.3b
Operates as contract development and manufacturing organization (CDMO) company in China and internationally.
603456
CN¥15.08
7D
3.0%
1Y
-7.9%
Sanofi
Market Cap: €92.5b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€75.50
7D
-0.4%
1Y
-8.7%
Supernus Pharmaceuticals
Market Cap: US$2.8b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$47.35
7D
0.2%
1Y
39.4%
Vetoquinol
Market Cap: €846.1m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
VETO
€72.80
7D
1.7%
1Y
-7.7%
Dong-A Socio Holdings
Market Cap: ₩538.3b
Engages in the pharmaceutical business in South Korea.
A000640
₩81,200.00
7D
-5.1%
1Y
-30.5%
Hugel
Market Cap: ₩2.5t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩227,000.00
7D
-8.5%
1Y
-36.5%
Yunnan Baiyao GroupLtd
Market Cap: CN¥89.3b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥50.05
7D
2.9%
1Y
-10.0%
Diaceutics
Market Cap: UK£120.2m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.42
7D
-3.1%
1Y
21.9%
Ardelyx
Market Cap: US$1.3b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$5.14
7D
-3.7%
1Y
11.5%
Bavarian Nordic
Market Cap: DKK 14.1b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 183.90
7D
-2.4%
1Y
1.9%
Virbac
Market Cap: €2.7b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
VIRP
€322.00
7D
-1.4%
1Y
-5.6%
Dong-E-E-Jiao
Market Cap: CN¥31.3b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥49.07
7D
4.6%
1Y
0.06%
Decibel Cannabis
Market Cap: CA$63.5m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
0%
1Y
27.8%
Tarsus Pharmaceuticals
Market Cap: US$2.5b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$59.31
7D
-11.5%
1Y
42.8%
Journey Medical
Market Cap: US$190.3m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.86
7D
-5.0%
1Y
-7.4%
Fennec Pharmaceuticals
Market Cap: US$364.4m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$10.75
7D
0.6%
1Y
22.3%
Amoy Diagnostics
Market Cap: CN¥6.9b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥17.91
7D
4.1%
1Y
-23.5%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.22
7D
-0.8%
1Y
-10.9%
Dong-A ST
Market Cap: ₩334.9b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩34,750.00
7D
-3.2%
1Y
-27.2%
Exagen
Market Cap: US$107.5m
Designs, develops, and commercializes various testing products under the AVISE brand in the United States.
XGN
US$4.14
7D
-5.9%
1Y
-41.4%
Perrigo
Market Cap: US$1.4b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$10.17
7D
-8.3%
1Y
-62.9%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩122,500.00
7D
-8.9%
1Y
-25.5%
United Laboratories International Holdings
Market Cap: HK$18.0b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$9.12
7D
-0.5%
1Y
-37.8%
China Resources Pharmaceutical Group
Market Cap: HK$29.0b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.62
7D
3.8%
1Y
-12.5%
TG Therapeutics
Market Cap: US$8.1b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$55.01
7D
-0.8%
1Y
41.3%
Amphastar Pharmaceuticals
Market Cap: US$825.4m
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$19.29
7D
-1.6%
1Y
-12.1%
ACADIA Pharmaceuticals
Market Cap: US$4.5b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$25.50
7D
-1.0%
1Y
16.5%